Severe shoulder tendinopathy associated with levofloxacin

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 4, 2012, Pages 393-395

  de Araujo Eyer Silva, Walter ^a   de Barros Pinto Netto, Henrique ^b   Francisco da Cunha Pinto, Jorge ^a   de Almeida Ferry, Fernando Raphael ^a   Neves Motta, Rogério ^a  

^a HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

Author keywords

Fluoroquinolone; Levofloxacin; Tendinitis; Tendinopathy

Indexed keywords

LEVOFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; ARTHROSCOPY; ARTICLE; ASYMPTOMATIC DISEASE; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; JOINT SURGERY; LOWER RESPIRATORY TRACT INFECTION; MALAISE; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PHYSIOTHERAPY; REST; RIGOR; SHOULDER PAIN; SHOULDER TENDINOPATHY; SPLINTING; SURGICAL TECHNIQUE; SUTURE; TENDINITIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OFLOXACIN; PNEUMONIA, BACTERIAL; SEVERITY OF ILLNESS INDEX; SHOULDER PAIN; TENDINOPATHY;

EID: 84864336811     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.06.015     Document Type: Article

References (11)

1. Khaliq Y., Zhanel G.G. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003, 36:1404-1410.
2. Bailey R.R., Kirk J.A., Peddie B.A. Norfloxacin-induced rheumatic disease. N Z Med J 1983, 96:590.
3. Fraunfelder F.W., Fraunfelder F.T. Diplopia and fluoroquinolones. Ophthalmology 2009, 116:1814-1817.
4. FDA. Information for healthcare professionals: fluoroquinolone antimicrobial drugs [ciprofloxacin (marketed as Cipro and generic ciprofloxacin), ciprofloxacin extended-release (marketed as Cipro XR and Proquin XR), gemifloxacin (marketed as Factive), levofloxacin (marketed as Levaquin), moxifloxacin (marketed as Avelox), norfloxacin (marketed as Noroxin), and ofloxacin (marketed as Floxin)], 2008.
5. Simonin M.A., Gegout-Pottie P., Minn A., Gillet P., Netter P., Terlain B. Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother 2000, 44:867-872.
6. Waterston S.W., Maffulli N., Ewen S.W. Subcutaneous rupture of the Achilles tendon: basic science and some aspects of clinical practice. Br J Sports Med 1997, 31:285-298.
7. Hall M.M., Finnoff J.T., Smith J. Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population. PM R 2011, 3:132-142.
8. Eisele S., Garbe E., Zeitz M., Schneider T., Somasundaram R. Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature. Int J Clin Pharmacol Ther 2009, 47:165-168.
9. Burkhardt J.E., Hill M.A., Carlton W.W., Kesterson J.W. Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 1990, 27:162-170.
10. Ng W.F., Naughton M. Fluoroquinolone-associated tendinopathy: a case report. J Med Case Reports 2007, 1:55.
11. van der Linden P.D., Sturkenboom M.C., Herings R.M., Leufkens H.M., Rowlands S., Stricker B.H. Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003, 163:1801-1807.